Novo Nordisk Aktie
61,39
EUR
+1,16
EUR
+1,93
%
61,50
EUR
+1,13
EUR
+1,87
%
Werbung
Novo Nordisk Aktie Analyse
20.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
17.01.20 | Novo Nordisk overweight | Barclays Capital | |
17.01.20 | Novo Nordisk Neutral | UBS AG | |
17.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.01.20 | Novo Nordisk overweight | Barclays Capital | |
16.01.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.01.20 | Novo Nordisk neutral | Morgan Stanley | |
06.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
Werbung
|
|||
06.01.20 | Novo Nordisk kaufen | Bernstein Research | |
17.12.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
12.12.19 | Novo Nordisk Hold | Deutsche Bank AG | |
06.12.19 | Novo Nordisk Neutral | UBS AG | |
27.11.19 | Novo Nordisk Reduce | HSBC | |
21.11.19 | Novo Nordisk Hold | Deutsche Bank AG | |
21.11.19 | Novo Nordisk Neutral | UBS AG | |
21.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
21.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
18.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
18.11.19 | Novo Nordisk Neutral | UBS AG | |
18.11.19 | Novo Nordisk overweight | Barclays Capital | |
11.11.19 | Novo Nordisk Hold | Deutsche Bank AG | |
06.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.19 | Novo Nordisk Outperform | Credit Suisse Group | |
04.11.19 | Novo Nordisk Equal weight | Barclays Capital | |
04.11.19 | Novo Nordisk Hold | Deutsche Bank AG | |
04.11.19 | Novo Nordisk Outperform | Bernstein Research | |
04.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
01.11.19 | Novo Nordisk Equal weight | Barclays Capital | |
01.11.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
01.11.19 | Novo Nordisk buy | UBS AG | |
01.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
28.10.19 | Novo Nordisk Outperform | Credit Suisse Group | |
21.10.19 | Novo Nordisk buy | UBS AG | |
09.10.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.10.19 | Novo Nordisk Outperform | Credit Suisse Group | |
30.09.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
27.09.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
24.09.19 | Novo Nordisk Hold | Deutsche Bank AG | |
23.09.19 | Novo Nordisk Equal weight | Barclays Capital | |
23.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
23.09.19 | Novo Nordisk Hold | Deutsche Bank AG | |
23.09.19 | Novo Nordisk Reduce | HSBC | |
20.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
20.09.19 | Novo Nordisk Halten | Independent Research GmbH | |
20.09.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
19.09.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
18.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
13.09.19 | Novo Nordisk Neutral | Merrill Lynch & Co., Inc. | |
12.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
09.09.19 | Novo Nordisk Outperform | Bernstein Research |
Werbung
Werbung